ProShare Advisors’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

ProShare Advisors’s Portfolio SURF Stock Details SURF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-11,399	Closed	-$33K	–	2221
2022 Q1	$33K	Sell	11,399 -2,817	-20%	-$9.87K	﹤0.01%	2147
2021 Q4	$68K	Buy	14,216 +45	+0.3%	+$290	﹤0.01%	2247
2021 Q3	$107K	Sell	14,171 -2,265	-14%	-$14.5K	﹤0.01%	1906
2021 Q2	$123K	Buy	+16,436	New	+$127K	﹤0.01%	2263
2019 Q2	–	Sell	-10,632	Closed	-$51K	–	1665
2019 Q1	$51K	Buy	10,632 +58	+0.5%	+$285	﹤0.01%	1614
2018 Q4	$45K	Buy	+10,574	New	+$81.7K	﹤0.01%	1528

Other funds holding SURF

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

AVAI

Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ProShare Advisors's SURF Position: Q2 2022 in Review

ProShare Advisors sold out of Surface Oncology, Inc. Common Stock (SURF) in Q2 2022, closing a stake of 11,399 shares — an estimated $33K sold.

ProShare Advisors first reported a position in SURF in Q4 2018 and held it in 6 quarters. The position peaked at $123K in Q2 2021. 84 funds tracked by Wall St. Rank hold SURF as of Q2 2022.

ProShare Advisors reported no remaining Surface Oncology, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
ProShare Advisors sold 11,399 Surface Oncology, Inc. Common Stock shares in Q2 2022, an estimated $33K.
ProShare Advisors first reported a position in Surface Oncology, Inc. Common Stock in Q4 2018 and held it in 6 quarters.
ProShare Advisors's Surface Oncology, Inc. Common Stock position peaked at $123K in Q2 2021.
84 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q2 2022.

Based on ProShare Advisors's 13F filing for Q2 2022, filed 1 Aug 2022.